Paradigm Capital Management, LLC/NV

Position in MRK — Merck & Co., Inc.

CIK 1910312 RENO, NV

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,608,794

-$56,322 QoQ

Shares Held

28,084

-7.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

4.70%

of 13F equity value

Holder Rank

#1,221

of 3,769 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Paradigm Capital Management, LLC/NV holds $8,119,187 across 5 Drug Manufacturers - General names. MRK ranks #1 (44.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc. This page	28,084	$3,608,794
2	JNJ	Johnson & Johnson	8,100	$2,057,157
3	AMGN	Amgen Inc	4,435	$1,606,002
4	PFE	Pfizer Inc	21,699	$522,511
5	NVS	Novartis AG	2,072	$324,723

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,608,794	28,084	-7.8%	Shares	Sole	2026-08-14
2026-03-31	$3,665,116	30,469	-1.6%	Shares	Sole	2026-05-06
2025-12-31	$3,259,796	30,969	+0.9%	Shares	Sole	2026-02-06
2025-09-30	$2,575,727	30,689	+4.5%	Shares	Sole	2025-11-06
2025-06-30	$2,324,137	29,360	+14.6%	Shares	Sole	2025-08-14
2025-03-31	$2,299,651	25,620	+6.0%	Shares	Sole	2025-05-14
2024-12-31	$2,404,531	24,171	+4.6%	Shares	Sole	2025-02-14
2024-09-30	$2,624,939	23,115	-3.5%	Shares	Sole	2024-11-14
2022-12-31	$2,658,029	23,957	-0.2%	Shares	Sole	2023-02-14
2022-09-30	$2,067,396	24,006	-2.4%	Shares	Sole	2022-11-14
2022-06-30	$2,242,508	24,597	-0.2%	Shares	Sole	2022-08-12
2022-03-31	$2,022,204	24,646	+7.5%	Shares	Sole	2022-05-13
2021-12-31	$1,756,665	22,921	—	Shares	Sole	2022-02-10
No filing history on record for this holder in this stock.